• 제목/요약/키워드: National Health Insurance Service regional office

검색결과 4건 처리시간 0.017초

노인장기요양보험 지역별 인정률 결정요인에 대한 패널분석 (A Panel Study on the Determinants of the Regional Variation in the Rate of Certification in Long-Term Care Insurance)

  • 사공진;송현종
    • 보건행정학회지
    • /
    • 제27권1호
    • /
    • pp.56-62
    • /
    • 2017
  • Background: There have been deviations in the regional rate of certification in Korean long-term care insurance (LTCI). This study aimed to explore the determinants of the rate of certification in LTCI. Methods: The panel data of the year 2010-2014 of the 227 National Health Insurance Service (NHIS) regional office were used. Making use of 26 explanatory variables (socio-demographic factors, access to the long-term care services, etc.), we estimated the random effects model using STATA SE ver. 13.0 program (Stata Corp., College Station, TX, USA) and tried to find out the determinants of the regional rate of certification. Results: Estimation results showed that the most important determinants of the regional rate of certification in LTCI are the long-term care infrastructure such as capacity or number of the homecare service institution, sanatorium, or convalescent hospital. The number of the elderly who lives alone and the dimentia patients were positively related to the regional rate of certification in LTCI. Conclusion: The estimation results implied that the regional variation in the rate of certification in LTCI has nothing to do with the NHIS regional offices or their employees. To alleviate the deviation in the regional rate of certification in LTCI, we suggested the analysis of the deviation in the survey checklist. We also proposed to found the regional comprehensive support center to prevent the geriatric illness and to improve the residents' health, etc.

국민건강보험공단 자료에서 비만실태 파악을 위한 이상치 진단 및 해결 (Outlier Diagnostics and Resolution to determine Obesity Status in the Korean National Health Insurance Research Database)

  • 김동욱;윤호순
    • 한국콘텐츠학회논문지
    • /
    • 제17권9호
    • /
    • pp.476-485
    • /
    • 2017
  • 본 연구는 2002년에서 2013년까지 국민건강보험공단 건강검진을 받은 대상자 자료를 통해 세계비만연맹 아시아-태평양지회(WHO-WPRO)에서 정한 체질량지수(Body Mess Index, BMI)을 기준으로 총 6개의 분류(저체중, 정상, 과체중, 비만, 고도비만, 초고도비만)로 구분하여 비만의 실태를 분석하였고 그 과정에 발생하는 이상치의 문제점들을 함께 해결하여 정확한 결과를 제시하고자 하였다. 본 연구 결과에서 제시하는 중앙값 반복 보간법은 선형 보간법이나 라그랑주 보간법에서 발생하는 다중 이상치 생성 시 잘못된 결과들이 보간되는 문제를 해결할 수 있는 유용한 방법으로 평가되었고, 이를 통해 최종 생성된 자료의 연간 비만지수변화를 확인한 결과 극단적인 저체중과 비만체중이 점차 증가하고 정상체중의 빈도가 점차 줄어드는 특징을 확인하였다. 특히 여성보다는 남성이 그리고 저 연령층에서 비만의 증가추세가 급증하고 있는 상태로 분석되었다. 전체적으로 본 연구 결과를 통해 비만으로 발생하는 건강문제가 또 다른 사회적 문제로 확산되기 전에 국가적인 조치가 필요한 것을 시사하고 있다.

Japanese Cancer Association Meeting UICC International Session - What is Cost-effectiveness in Cancer Treatment?

  • Akaza, Hideyuki;Kawahara, Norie;Roh, Jae Kyung;Inoue, Hajime;Park, Eun-Cheol;Lee, Kwang-Sig;Kim, Sukyeong;Hayre, Jasdeep;Naidoo, Bhash;Wilkinson, Thomas;Fukuda, Takashi;Jang, Woo Ick;Nogimori, Masafumi
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권1호
    • /
    • pp.3-10
    • /
    • 2014
  • The Japan National Committee for the Union for International Cancer Control (UICC) and UICC-Asia Regional Office (ARO) organized an international session as part of the official program of the 72nd Annual Meeting of the Japanese Cancer Association to discuss the topic "What is cost-effectiveness in cancer treatment?" Healthcare economics are an international concern and a key issue for the UICC. The presenters and participants discussed the question of how limited medical resources can be best used to support life, which is a question that applies to both developing and industrialized countries, given that cancer treatment is putting medical systems under increasing strain. The emergence of advanced yet hugely expensive drugs has prompted discussion on methodologies for Health Technology Assessment (HTA) that seek to quantify cost and effect. The session benefited from the participation of various stakeholders, including representatives of industry, government and academia and three speakers from the Republic of Korea, an Asian country where discussion on HTA methodologies is already advanced. In addition, the session was joined by a representative of National Institute for Health and Care Excellence (NICE) of the United Kingdom, which has pioneered the concept of cost-effectiveness in a medical context. The aim of the session was to advance and deepen understanding of the issue of cost-effectiveness as viewed from medical care systems in different regions.

Viral Hepatitis and Liver Cancer in Korea: an Epidemiological Perspective

  • Yeo, Yohwan;Gwack, Jin;Kang, Seokin;Koo, Boyeon;Jung, Sun Jae;Dhamala, Prakash;Ko, Kwang-Pil;Lim, Young-Khi;Yoo, Keun-Young
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권11호
    • /
    • pp.6227-6231
    • /
    • 2013
  • In the past, hepatitis B virus (HBV) infection was endemic in the general Korean population. The association of HBV infection with the occurrence of liver cancer has been well demonstrated in several epidemiologic studies. While the mortality rates of liver cancer in Korea have decreased steadily over the last decade, the presence of hepatitis B surface antigen (HBsAg) in mothers remains high at 3-4%, and 25.5% of these HBsAg positive mothers are positive for hepatitis B e antigen (HBeAg). HBV infection caused almost a quarter of hepatocellular carcinoma (HCC) cases and one-third of deaths from HCC. These aspects of HBV infection prompted the Korean government to create a vaccination program against HBV in the early 1980s. In 1995, the Communicable Disease Prevention Act (CDPA) was reformed, and the government increased the number of HBV vaccines in the National Immunization Program (NIP), driving the vaccination rate up to 95%. In 2000, the National Health Insurance Act (NHIA) was enacted, which provided increased resources for the prevention of perinatal HBV infection. Then in 2002, the Korean government, in conjunction with the Korean Medical Association (KMA), launched an HBV perinatal transmission prevention program. The prevalence of HBsAg in children had been high (4-5%) in the early 1980s, but had dropped to below 1% in 1995, and finally reached 0.2% in 2006 after the NIP had been implemented. After the success of the NIP, Korea finally obtained its first certification of achievement from the Western Pacific Regional Office of the World Health Organization (WPRO-WHO) for reaching its goal for HBV control. An age-period-cohort analysis showed a significant reduction in the liver cancer mortality rate in children and adolescents after the NIP had been implemented. In addition to its vaccination efforts, Korea launched the National Cancer Screening Program (NCSP) for 5 leading sites of cancer, including the liver, in 1999. As a consequence of this program, the 5-year liver cancer survival rate increased from 13.2% (1996-2000) to 23.3% (2003-2008). The development of both the primary and secondary prevention for liver cancer including HBV immunization and cancer screening has been of critical importance.